COLD vs SRPT · rev $2.67B vs rev $1.90B
Americold Realty Trust (COLD) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
COLD currently screens at market cap $4.75B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the COLD and SRPT stock pages for the full models.
Not investment advice.